𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial and cost analysis of fazarabine in advanced nonsmall cell carcinoma of the lung: A southwest oncology group study

Book ID
123379994
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
139 KB
Volume
14
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of cisplatin, carboplatin, an
Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group
✍ Robert A. Figlin; John J. Crowley; Edwin L. Jacobs; Michael Muirhead; John Wenda πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## BACKGROUND. The combined use of cisplatin and carboplatin chemotherapy offers a unique means of platinum dose intensification. Response rates using either of these agents in combination with etoposide are comparable. In a Phase II trial, the authors investigated the combination of cisplatin and

Phase II trial of carboplatin and paclit
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study
✍ Ulka N. Vaishampayan; James R. Faulkner; Eric J. Small; Bruce G. Redman; Wayne L πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND The purpose of the study was to assess the efficacy and toxicity of carboplatin and paclitaxel administered every 3 weeks in patients with advanced urothelial carcinoma, previously treated with cisplatin‐based therapy. ## METHODS Eligibility included metastatic or local